About Compass

We now know that long term infection with certain types of Human Papillomavirus (HPV) is the main cause of cervical cancer. Overseas research has shown that a test for these HPV types is, in fact, a better cervical cancer screening test than the Pap smear.

Compass is a randomized controlled trial to compare 2.5-yearly cytology-based cervical screening with 5-yearly primary HPV screening in Australian women aged 25-69. As of April 2016, we have now completed and closed recruitment of "older" unvaccinated women. Currently, eligible participants are women, aged 25-35/36 years (born after 30th June 1980), attending for routine screening at Participating Health Practices.

Compass is being carried out by VCS in collaboration with The Cancer Council NSW. For more information please see For Women